Current Biochemical Applications and Future Prospects of Chlorotoxin in Cancer Diagnostics and Therapeutics
Sbonelo Khanyile, Priscilla Masamba, Babatunji Emmanuel Oyinloye and 2 more
Advanced Pharmaceutical Bulletin · 2019
doi:10.15171/apb.2019.061 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Chlorotoxin (CTX) is a minute 4 kDa protein made up of 36 amino acid residues, commonlyknown for its binding affinity to chloride channels and matrix metalloproteinase-2 (MMP-2)of glioma tumors of the spine and brain. This property and the possibility of conjugating thispeptide to nanoparticles have enabled its diverse use in various biotechnological and biomedicalapplications for cancer treatment, such as in tumor imaging and radiotherapy. Because of thefascinating biological properties CTX possesses, elucidating its mechanism of action may holdpromise for the development of new and effective therapeutic drugs, as well as more sensitiveand highly specific cancer-screening kits. This article therefore reviews the currently knownapplications of CTX and suggests diverse ways in which it can be applied for the design ofimproved drugs and diagnostic tools for cancer.
Abstract licence: CC BY
References104
- 35.
39 more references, whose wording the paper’s licence keeps private.
All 104 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.